Lv2
144 积分 2025-01-09 加入
CLC2 (clathrin light chain 2)-ATG8h/ATG8i interactions connect clathrin-mediated endocytosis (CME) and the autophagy pathway
1天前
待确认
MYC/TET3‐Regulated TMEM65 Activates OXPHOS‐SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple‐Negative Breast Cancer
1天前
已完结
Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma
2天前
已完结
Discovery of potent small molecule PROTACs targeting mutant EGFR
14天前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
14天前
已完结
Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer
18天前
已完结
Antitumour immunity regulated by aberrant ERBB family signalling
19天前
已完结
Epidermal growth factor receptor mutations in breast Cancer: Therapeutic challenges and way forward
22天前
已完结
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
1个月前
已完结
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
1个月前
已完结
皖公网安备34019202002308
